首页> 外文期刊>Perspectives in vascular surgery and endovascular therapy. >Results of stenting for postthrombotic venous obstructive lesions
【24h】

Results of stenting for postthrombotic venous obstructive lesions

机译:血栓后静脉阻塞性病变的支架置入结果

获取原文
获取原文并翻译 | 示例
           

摘要

Venous obstructive lesions represent a therapeutic challenge. Postthrombotic lesions are the most complex and very prone to rethrombosis. Technical success can be achieved in more than 85% of the cases (100% when recanalization with thrombolysis is not needed) with a low rate of periprocedural complications and no mortality. The overall rate of thrombotic events after stenting is around 5%. Patency rates depend on multiple criteria, including the need for thrombolysis and the involvement of the common femoral vein and of the inferior vena cava. Primary, assisted-primary, and secondary patency rates were 67%, 89%, and 93%, respectively, at 6 years in the study by Neglén and 66%, 70%, and 77%, respectively, in the intention-to-treat European multicentric study, at 5 and 10 years. Stenting is a minimally invasive and safe technique with good long-term clinical results and patency rates. It represents the method of choice for the treatment of postthrombotic iliofemoral venous obstructions.
机译:静脉阻塞性病变代表治疗挑战。血栓形成后的病变是最复杂的,非常容易发生血栓形成。超过85%的病例(不需要溶栓再通时为100%)可实现技术成功,围手术期并发症发生率低且无死亡率。支架置入后血栓事件的总发生率约为5%。通畅率取决于多种标准,包括是否需要溶栓,股总静脉和下腔静脉是否受累。内格伦(Neglén)的研究在6年时的主要通畅率,辅助主要通畅率和次要通畅率分别为67%,89%和93%,意向达到对待欧洲多中心研究,分别为5年和10年。支架置入术是一种微创和安全的技术,具有良好的长期临床效果和通畅率。它代表了治疗血栓形成后股股静脉梗阻的首选方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号